Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sunwoo | - |
dc.contributor.author | Oh, Taejeong | - |
dc.contributor.author | Chung, Hyuncheol | - |
dc.contributor.author | Rha, Sunyoung | - |
dc.contributor.author | Kim, Changjin | - |
dc.contributor.author | Moon, Youngho | - |
dc.contributor.author | Hoehn, Benjamin D. | - |
dc.contributor.author | Jeong, Dongjun | - |
dc.contributor.author | Lee, Seunghoon | - |
dc.contributor.author | Kim, Namkyu | - |
dc.contributor.author | Park, Chanhee | - |
dc.contributor.author | Yoo, Miae | - |
dc.contributor.author | An, Sungwhan | - |
dc.date.accessioned | 2021-08-12T03:28:17Z | - |
dc.date.available | 2021-08-12T03:28:17Z | - |
dc.date.issued | 2012-03 | - |
dc.identifier.issn | 1019-6439 | - |
dc.identifier.issn | 1791-2423 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/15346 | - |
dc.description.abstract | Aberrant methylation of CpG islands in the promoter region of genes is a common epigenetic phenomenon found in early cancers. Therefore conducting genome-scale methylation studies will enhance our understanding of the epigenetic etiology behind carcinogenesis by providing reliable biomarkers for early detection of cancer. To discover novel hypermethylated genes in colorectal cancer by genome-wide search, we first defined a subset of genes epigenetically reactivated in colon cancer cells after treatment with a demethylating agent. Next, we identified another subset of genes with relatively down-regulated expression patterns in colorectal primary tumors when compared with normal appearing-adjacent regions. Among 29 genes obtained by cross-comparison of the two gene-sets, we subsequently selected, through stepwise subtraction processes, two novel genes, GABRA1 and LAMA2, as methylation targets in colorectal cancer. For clinical validation pyrosequencing was used to assess methylation in 134 matched tissue samples from CRC patients. Aberrant methylation at target CpG sites in GABRA1 and LAMA2 was observed with high frequency in tumor tissues (92.5% and 80.6%, respectively), while less frequently in matched tumor-adjacent normal tissues (33.6% for GABRA1 and 13.4% for LAMA2). Methylation levels in primary tumors were not significantly correlated with clinicopathological features including age, sex, survival and TNM stage. Additionally, we found that ectopic overexpression of GABRA1 in colon cancer cell lines resulted in strong inhibition of cell growth. These results suggest that two novel hypermethylated genes in colorectal cancer, GABRA1 and LAMA2, may have roles in colorectal tumorigenesis and could be potential biomarkers for the screening and the detection of colorectal cancer in clinical practice. | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Demetrios A. Spandidos Ed. & Pub. | - |
dc.title | Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer | - |
dc.type | Article | - |
dc.publisher.location | 그리이스 | - |
dc.identifier.doi | 10.3892/ijo.2011.1245 | - |
dc.identifier.scopusid | 2-s2.0-84863151977 | - |
dc.identifier.wosid | 000300118200032 | - |
dc.identifier.bibliographicCitation | International Journal of Oncology, v.40, no.3, pp 889 - 898 | - |
dc.citation.title | International Journal of Oncology | - |
dc.citation.volume | 40 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 889 | - |
dc.citation.endPage | 898 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | HISTONE DEACETYLASE INHIBITION | - |
dc.subject.keywordPlus | TUMOR-SUPPRESSOR GENE | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | HYPERMETHYLATION | - |
dc.subject.keywordPlus | DEMETHYLATION | - |
dc.subject.keywordPlus | PROMOTER | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.subject.keywordPlus | BIOMARKERS | - |
dc.subject.keywordPlus | SERUM | - |
dc.subject.keywordPlus | MYC | - |
dc.subject.keywordAuthor | colorectal cancer | - |
dc.subject.keywordAuthor | methylation | - |
dc.subject.keywordAuthor | genome-wide | - |
dc.subject.keywordAuthor | microarray | - |
dc.subject.keywordAuthor | GABRA1 | - |
dc.subject.keywordAuthor | LAMA2 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.